Clover Biopharmaceuticals, Ltd.
HKEX:2197.HK
Overview | Financials
Company Name | Clover Biopharmaceuticals, Ltd. |
Symbol | 2197.HK |
Currency | HKD |
Price | 0.218 |
Market Cap | 282,756,650 |
Dividend Yield | 0% |
52-week-range | 0.201 - 0.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joshua G. Liang |
Website | https://www.cloverbiopharma.com |
An error occurred while fetching data.
About Clover Biopharmaceuticals, Ltd.
Clover Biopharmaceuticals, Ltd., a biotechnology company, engages in the research, development, and commercialization of novel vaccines and biologic therapeutic candidates for infectious diseases, and cancer and autoimmune diseases. It is developing SCB-2019 (CpG 1018/Alum), a COVID-19 vaccine candidate that is in Phase II/III clinical trial; SCB-313, a trimeric fusion protein
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD